Director Shareholding

GlaxoSmithKline PLC 04 December 2002 Directors' Interests I give below details of changes in the directors' interests in the Ordinary Shares (Shares) and American Depositary Shares (ADSs) of GlaxoSmithKline plc. Each ADS represents two Ordinary Shares. On 3 December 2002, under the Rules of the GlaxoSmithKline Performance Share Plan, Target Awards were granted over Ordinary Shares and ADSs in the Company to the directors listed below: Ordinary Shares American Depository Shares Dr J-P Garnier 70,000 Mr J D Coombe 40,000 On the same day, options to acquire the Company's Shares and ADSs were granted under the GlaxoSmithKline Share Option Plan to the directors listed below: Ordinary Shares Subscription Price American Depository Subscription Price Shares Dr J-P Garnier 450,000 $37.25 Mr J D Coombe 290,000 £11.79 Under the terms of the GlaxoSmithKline Performance Share Plan (which was approved by Shareholders on 31 July 2000), Target Awards are granted annually to eligible executives, designating a number of Shares/ADSs that may be awarded, dependent upon the Company's performance over a three year measurement period. The three year measurement period for the Target Awards granted on 3 December 2002 will commence on 1 January 2003 and end on 31 December 2005. The grant of options is made under the GlaxoSmithKline Share Option Plan which was approved by Shareholders on 31st July 2000. A performance condition has been set for the vesting of the options granted to the above directors. The Target Awards and Share Options, set out above have been granted to Dr Garnier and Mr Coombe at the same level as last year. S M Bicknell Company Secretary 4 December 2002 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings